Development of AOP-Informed Predictive Models for Screening Chemicals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Induction Potential
ACS ES&T Toxicology · 02.11.2026
DOI: 10.1021/acsesttox.6c00050 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS ES&T Toxicology, online erschienen am 02.11.2026. Verfasst von Souvik Pore und 1 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major liver disease, particularly influenced by drug or chemical interactions that induce hepatic steatosis. An adverse outcome pathway (AOP) can help explain these effects. A major target in this process is the peroxisome proliferator-activated receptor (PPAR), with three isoforms─PPAR-α, PPAR-β/δ, and PPAR-γ─each playing a crucial role in lipid metabolism. In this study, we developed predictive models to assess a chemical’s potential to induce MASLD using AOP information, particularly AOP-36, which describes the development of hepatic steatosis due to reduced activation of PPAR-α, PPAR-β/δ, and PPAR-γ. We collected data from the ChEMBL database for three PPAR targets and developed models for the ‘Standard Type’ IC50. After curation, the collected datasets include 456 data points for PPAR-α, 310 for PPAR-β/δ, and 1006 for PPAR-γ. Initially, we developed machine learning-based quantitative structure–activity relationship (QSAR) models for all the targets, which show moderate predictive performance (Q2F1/F2 ∼ 0.57–0.62). Then similarity-based read-across predictions were performed, where all datasets showed improved predictive performance (Q2F1/F2 ∼ 0.65–0.70). We also developed machine learning-based quantitative read-across structure–activity relationship (q-RASAR) models, which also show improved predictive performance (Q2F1/F2 ∼ 0.65–0.70).
Förderung
- Indian Council of Medical Research
Zitieren
APA
Pore, S., & Roy, K. (2026). Development of AOP-Informed Predictive Models for Screening Chemicals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Induction Potential. ACS ES&T Toxicology. https://doi.org/10.1021/acsesttox.6c00050
Vancouver
Pore S, Roy K. Development of AOP-Informed Predictive Models for Screening Chemicals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Induction Potential. ACS ES&T Toxicology. 2026. doi:10.1021/acsesttox.6c00050
BibTeX
@article{Pore2026,
author = {Pore, Souvik and Roy, Kunal},
title = {Development of AOP-Informed Predictive Models for Screening Chemicals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Induction Potential},
journal = {ACS ES&T Toxicology},
year = {2026},
doi = {10.1021/acsesttox.6c00050}
}
EUVIMED